2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

https://hull-repository.worktribe.com/preview/1797952/1-s2.0-S0140673618322797-main.pdf

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

WRITING GROUP MEMBERS Emelia J. Benjamin, MD, SCM, FAHA Michael J. Blaha, MD, MPH Stephanie E. Chiuve, ScD Mary Cushman, MD, MSc, FAHA Sandeep R. Das, MD, MPH, FAHA Rajat Deo, MD, MTR Sarah D. de Ferranti, MD, MPH James Floyd, MD, MS Myriam Fornage, PhD, FAHA Cathleen Gillespie, MS Carmen R. Isasi, MD, PhD, FAHA Monik C. Jiménez, ScD, SM Lori Chaffin Jordan, MD, PhD Suzanne E. Judd, PhD Daniel Lackland, DrPH, FAHA Judith H. Lichtman, PhD, MPH, FAHA Lynda Lisabeth, PhD, MPH, FAHA Simin Liu, MD, ScD, FAHA Chris T. Longenecker, MD Rachel H. Mackey, PhD, MPH, FAHA Kunihiro Matsushita, MD, PhD, FAHA Dariush Mozaffarian, MD, DrPH, FAHA Michael E. Mussolino, PhD, FAHA Khurram Nasir, MD, MPH, FAHA Robert W. Neumar, MD, PhD, FAHA Latha Palaniappan, MD, MS, FAHA Dilip K. Pandey, MBBS, MS, PhD, FAHA Ravi R. Thiagarajan, MD, MPH Mathew J. Reeves, PhD Matthew Ritchey, PT, DPT, OCS, MPH Carlos J. Rodriguez, MD, MPH, FAHA Gregory A. Roth, MD, MPH Wayne D. Rosamond, PhD, FAHA Comilla Sasson, MD, PhD, FAHA Amytis Towfighi, MD Connie W. Tsao, MD, MPH Melanie B. Turner, MPH Salim S. Virani, MD, PhD, FAHA Jenifer H. Voeks, PhD Joshua Z. Willey, MD, MS John T. Wilkins, MD Jason HY. Wu, MSc, PhD, FAHA Heather M. Alger, PhD Sally S. Wong, PhD, RD, CDN, FAHA Paul Muntner, PhD, MHSc On behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart Disease and Stroke Statistics—2017 Update

Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association

Author(s): Writing Group Members; Mozaffarian, Dariush; Benjamin, Emelia J; Go, Alan S; Arnett, Donna K; Blaha, Michael J; Cushman, Mary; Das, Sandeep R; de Ferranti, Sarah; Despres, Jean-Pierre; Fullerton, Heather J; Howard, Virginia J; Huffman, Mark D; Isasi, Carmen R; Jimenez, Monik C; Judd, Suzanne E; Kissela, Brett M; Lichtman, Judith H; Lisabeth, Lynda D; Liu, Simin; Mackey, Rachel H; Magid, David J; McGuire, Darren K; Mohler, Emile R; Moy, Claudia S; Muntner, Paul; Mussolino, Michael E; Nasir, Khurram; Neumar, Robert W; Nichol, Graham; Palaniappan, Latha; Pandey, Dilip K; Reeves, Mathew J; Rodriguez, Carlos J; Rosamond, Wayne; Sorlie, Paul D; Stein, Joel; Towfighi, Amytis; Turan, Tanya N; Virani, Salim S; Woo, Daniel; Yeh, Robert W; Turner, Melanie B; American Heart Association Statistics Committee; Stroke Statistics Subcommittee

Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association

March 5, 2019 e1 WRITING GROUP MEMBERS Emelia J. Benjamin, MD, ScM, FAHA, Chair Paul Muntner, PhD, MHS, FAHA, Vice Chair Alvaro Alonso, MD, PhD, FAHA Marcio S. Bittencourt, MD, PhD, MPH Clifton W. Callaway, MD, FAHA April P. Carson, PhD, MSPH, FAHA Alanna M. Chamberlain, PhD Alexander R. Chang, MD, MS Susan Cheng, MD, MMSc, MPH, FAHA Sandeep R. Das, MD, MPH, MBA, FAHA Francesca N. Delling, MD, MPH Luc Djousse, MD, ScD, MPH Mitchell S.V. Elkind, MD, MS, FAHA Jane F. Ferguson, PhD, FAHA Myriam Fornage, PhD, FAHA Lori Chaffin Jordan, MD, PhD, FAHA Sadiya S. Khan, MD, MSc Brett M. Kissela, MD, MS Kristen L. Knutson, PhD Tak W. Kwan, MD, FAHA Daniel T. Lackland, DrPH, FAHA Tené T. Lewis, PhD Judith H. Lichtman, PhD, MPH, FAHA Chris T. Longenecker, MD Matthew Shane Loop, PhD Pamela L. Lutsey, PhD, MPH, FAHA Seth S. Martin, MD, MHS, FAHA Kunihiro Matsushita, MD, PhD, FAHA Andrew E. Moran, MD, MPH, FAHA Michael E. Mussolino, PhD, FAHA Martin O’Flaherty, MD, MSc, PhD Ambarish Pandey, MD, MSCS Amanda M. Perak, MD, MS Wayne D. Rosamond, PhD, MS, FAHA Gregory A. Roth, MD, MPH, FAHA Uchechukwu K.A. Sampson, MD, MBA, MPH, FAHA Gary M. Satou, MD, FAHA Emily B. Schroeder, MD, PhD, FAHA Svati H. Shah, MD, MHS, FAHA Nicole L. Spartano, PhD Andrew Stokes, PhD David L. Tirschwell, MD, MS, MSc, FAHA Connie W. Tsao, MD, MPH, Vice Chair Elect Mintu P. Turakhia, MD, MAS, FAHA Lisa B. VanWagner, MD, MSc, FAST John T. Wilkins, MD, MS, FAHA Sally S. Wong, PhD, RD, CDN, FAHA Salim S. Virani, MD, PhD, FAHA, Chair Elect On behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee

Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association

Objectives. Ar ange of medical conditions can lead to visual impairments either through effects on the eye or the visual pathways and brain. The prevalence of visual impairment increases with age. Furthermore, research evidence has shown that aging is related to a number of other processes that can lead to changes in cognitive functioning and sensory perception that may adversely affect driving (Marottoli and Drickamer, 1993; Stelmach and Nahom, 1992). This combination of factors is thought to contribute to older driver crash risk (Hakamies-Blomqvist, 1993; Stutts et al., 1998). Licensing authorities are the primary entity responsible for monitoring the medical fitness of their license holders. While it is important for licensing bodies to identify drivers who have conditions that place them at a heightened risk for crashes, at the same time, they should not unfairly restrict the mobility of disabled or aging drivers. Therefore, it is important that the licensing criteria for visual fitness to drive are based on scientific evidence establishing their effectiveness and predictive value for poor driving performance and unaceptable crash risk. The aim of this paper is to assess whether current licensing guidelines are consistent with the available scientific evidence on the effect of visual impairment on driving with a specific focus on older drivers. Methods. This article describes current licensing guidelines for vision from selected Western jurisdictions and reviews the available scientific evidence on visual impairment and driving performance on which such licensing decisions are based. Results. The findings of the review indicate that the predictive values of the vision tests commonly used for licensing decisions by the selected authorities are inconclusive. Discussion. The functional attributes of vision currently assessed for licensing do not adequately explain unsafe driving performance. Differences were observed across vision requirements for the selected jurisdictions, possibly reflecting the equivocal and inconclusive findings linking specific visual functions and impairment with crash risk. Setting benchmarks or performance thresholds on selected visual tests may be problematic for older drivers in particular, who are most vulnerable to underperforming. Driving involves a complex set of skills, and it is proposed that decisions about vision for safe driving need to be considered in the context of the driver’s overall health and other functional abilities.

Implications o f V ision T esting f or O lder D river Licensing

In Australia, the presence of a visual field deficit condition requires assessment by an optometrist or ophthalmologist before an individual can be considered fit-to-drive. However, there are currently limitations in the validity of tests and criteria used for assessing vision for safe driving. This paper examines the scope of the problem in one Australian jurisdiction by identifying the prevalence of visual field loss (VFL) amongst drivers referred for medical review and describing the current practices for managing their licence review. A random sample of medical review cases was extracted from the VicRoads Medical Review database to identify cases involving VFL conditions: glaucoma, age-related macular degeneration, diabetic retinopathy, hemianopia/quadrantanopia and retinitis pigmentosa. Data on demographic information, visual field loss conditions and the referral process were collected for all identified cases. (a) For the covering entry of this conference, please see ITRD abstract no. E216178.

Drivers with visual field loss in one Australian licensing jurisdiction

The proposed Australasian older driver licensing model incorporates a screening assessment of older drivers identified as being at-risk by health or other authorities. Some drivers are either failed or passed with drivers whose test performance has been inconclusive, being referred for further in-depth assessment. The useful field of view (UFOV) screening test has been extensively evaluated over the past decade or so, with results commonly confirming a statistically significant association between test performance and various measures of crash risk. An Austroads project currently being conducted in Western Australia involves a case-control study to assess the usefulness of UFOV and other assessment options to licensing authorities when assessing older drivers. Preliminary results based on 39 cases and 39 controls indicate that several measures have a statistically significant association with recent crash involvement. Once all testing has been completed, more sophisticated statistical analyses (e.g. a regression analysis, diagnostic accuracy testing) will be undertaken to evaluate the effectiveness of using these tests for screening older drivers. This paper explores the different ways in which UFOV and other measures of fitness to drive might assist in the assessment of older drivers generally and within the Australasian licensing model, specifically. (a) For the covering entry of this conference, please see ITRD abstract no. E216178.

Some options for assessing older driver fitness to drive for licensing purposes

The population burden of knee replacement surgery after sports injury

Mortality Rates, Readmissions and Revascularisation Following a First Myocardial Infarction In Patients With Autoimmune Rheumatic Disease Compared With Controls.

Megan Bohensky

Papers

Implications o f V ision T esting f or O lder D river Licensing

Drivers with visual field loss in one Australian licensing jurisdiction

Some options for assessing older driver fitness to drive for licensing purposes

The population burden of knee replacement surgery after sports injury

Mortality Rates, Readmissions and Revascularisation Following a First Myocardial Infarction In Patients With Autoimmune Rheumatic Disease Compared With Controls.